Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Axcella

Axcella Announces Upcoming Investor Conference Presentation
From Axcella
Via Business Wire
Tickers AXLA
Axcella Announces Upcoming Investor Conference Presentation
From Axcella
Via Business Wire
Tickers AXLA
Axcella Announces Publication in The American Journal of Gastroenterology of Positive Results from AXA1125-003 in Subjects With Presumed NASH
From Axcella
Via Business Wire
Tickers AXLA
Axcella Reports Second Quarter Financial Results and Provides Business Update
From Axcella
Via Business Wire
Tickers AXLA
Axcella to Report Second Quarter 2021 Financial Results on July 29, 2021
From Axcella
Via Business Wire
Tickers AXLA
Axcella Announces Initiation of EMMPOWER℠ Phase 2 Clinical Trial of AXA1665
From Axcella
Via Business Wire
Tickers AXLA
Positive Clinical Data About Axcella’s AXA1665 Candidate for Overt Hepatic Encephalopathy Highlighted in Oral Presentation at DDW 2021
From Axcella
Via Business Wire
Tickers AXLA
Axcella Announces Initiation of EMMPACT℠ Phase 2b Clinical Trial of AXA1125
From Axcella
Via Business Wire
Tickers AXLA
Axcella Announces Initiation of EMMPACTSM Phase 2b Clinical Trial of AXA1125
From Axcella
Via Business Wire
Tickers AXLA
Axcella Reports First Quarter Financial Results and Provides Business Update
From Axcella
Via Business Wire
Tickers AXLA
Axcella to Report First Quarter 2021 Financial Results on May 6, 2021
From Axcella
Via Business Wire
Tickers AXLA
Axcella Announces Upcoming Oral Presentation at Digestive Disease Week (DDW) 2021
From Axcella
Via Business Wire
Tickers AXLA
Axcella Announces AXA1125’s IND Clearance for the Treatment of NASH
From Axcella
Via Business Wire
Tickers AXLA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.